Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that typically results in death within 3–5 years after diagnosis. To date, there is no curative treatment and therefore an urgent unmet need of neuroprotective and/or neurorestorative treatments. Due to their spectrum of capaci...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouel, Flore, Rolland, Anne-Sophie, Devedjian, Jean-Christophe, Burnouf, Thierry, Devos, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688198/
https://www.ncbi.nlm.nih.gov/pubmed/31428042
http://dx.doi.org/10.3389/fneur.2019.00835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688198/
https://www.ncbi.nlm.nih.gov/pubmed/31428042
http://dx.doi.org/10.3389/fneur.2019.00835

Ejemplares similares